CEL-SCI CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
CEL-SCI CORPORATION (CVM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 39.51 thousand shares for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2019-08-14
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-06-30 was 39.51K shares.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-03-31 was 24.19K shares, a 252.87% increase year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-06-30 was 0.00 shares, a 100.00% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month as first filed |
|---|---|---|---|---|---|---|
| 2019-06-30 | 39.51K shares 10-Q · filed 2019-08-14 | 63.70K shares derived: sum of 2 quarters · filed 2019-08-14 | 63.70K shares 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | 24.19K shares 10-Q · filed 2019-05-14 | 24.19K shares 10-Q · filed 2019-05-14 | ||||
| 2018-12-31 | 0.00 shares 10-Q · filed 2019-02-14 | |||||
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-14 | 6.86K shares derived: sum of 2 quarters · filed 2019-08-14 | 1.39K shares 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | 6.86K shares 10-Q · filed 2019-05-14 | 1.39K shares 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | 809.00 shares 10-Q · filed 2019-02-14 | |||||
| 2017-06-30 | 919.00 shares 10-Q · filed 2018-08-14 | 1.98K shares derived: sum of 2 quarters · filed 2018-08-14 | 1.98K shares 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | 1.06K shares 10-Q · filed 2018-05-15 | 26.53K shares 10-Q · filed 2017-05-10 | 1.06K shares 10-Q · filed 2018-05-15 | 26.53K shares 10-Q · filed 2017-05-10 | ||
| 2016-12-31 | 0.00 shares 10-Q · filed 2018-02-12 | |||||
| 2016-06-30 | 200.00 shares 10-Q/A · filed 2017-12-11 | 5.00K shares 10-Q · filed 2016-08-09 | 1.32K shares derived: sum of 2 quarters · filed 2017-12-11 | 2.24K shares 10-Q/A · filed 2017-12-11 | 56.00K shares 10-Q · filed 2016-08-09 | |
| 2016-03-31 | 1.12K shares 10-Q/A · filed 2017-12-11 | 28.03K shares 10-Q · filed 2016-05-10 | 2.04K shares 10-Q/A · filed 2017-12-11 | 51.00K shares 10-Q · filed 2016-05-10 | ||
| 2015-12-31 | 919.00 shares 10-Q/A · filed 2017-12-11 | 22.97K shares 10-Q · filed 2016-02-09 | ||||
| 2015-06-30 | 27.83K shares 10-Q · filed 2016-08-09 | 39.75K shares derived: sum of 2 quarters · filed 2016-08-09 | 137.25K shares 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | 11.92K shares 10-Q · filed 2016-05-10 | 109.42K shares 10-Q · filed 2016-05-10 | ||||
| 2014-12-31 | 97.50K shares 10-Q · filed 2016-02-09 | |||||
| 2014-06-30 | 5.32K shares 10-Q · filed 2015-08-07 | 5.32K shares 10-Q · filed 2015-08-07 | ||||
| 2013-06-30 | 100.00K shares 10-Q · filed 2013-08-09 | |||||
| 2012-06-30 | 0.00 shares 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |